DifGen Pharmaceuticals LLC Receives USFDA Approval for Fluorometholone Ophthalmic Suspension, 0.1% - Expanding Its Complex Generic Portfolio

DifGen Pharmaceuticals, a leading US based generic pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (USFDA) for its Fluorometholone ...

Lupin gets USFDA nod for Brivaracetam Oral Solution

Lupin said it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Brivaracetam Oral Solution 10 mg/mL.
Morningstar

Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife

Jointly developed HIV-1 therapy leverages STEERLife's proprietary solvent-free FragMelt™ continuous processing platform to address complex formulation challenges NEW YORK and BENGALURU, India, Jan. 13 ...
Medical Dialogues

Lupin Secures USFDA Nod for Epilepsy Drug Brivaracetam in US

Mumbai: Mumbai-based pharmaceutical major Lupin Limited has received approval from the US Food and Drug Administration (USFDA) for its Brivaracetam Oral Solution 10 mg/mL and has launched ...
Pharmabiz

Lupin receives US FDA approval for brivaracetam oral solution

Lupin receives US FDA approval for brivaracetam oral solution: Our Bureau, Mumbai Wednesday, February 25, 2026, 14:20 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...
MarketWatch

Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife

NEW YORK and BENGALURU, India, Jan. 13, 2026 /PRNewswire/ -- Marking a significant milestone in the global effort to expand access to advanced HIV therapies, STEERLife (the life sciences division of ...